MAPT and Cognitive impairment: Because tau pathology is more strongly correlated with the degree of dementia than Aβ pathology, greater clinical efficacy may be achieved by clearing tau than by clearing Aβ aggregates in the later stages of the disease when cognitive impairments become evident [26].